Cable Hill Partners’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-500
Closed -$24K 1015
2017
Q4
$24K Buy
500
+300
+150% +$15K 0.01% 353
2017
Q3
$9K Buy
+200
New +$6.82K ﹤0.01% 626

Other funds holding JUNO

Cable Hill Partners's JUNO Position: Q1 2018 in Review

Cable Hill Partners sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 500 shares — an estimated $24K sold.

Cable Hill Partners first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $24K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Cable Hill Partners reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Cable Hill Partners sold 500 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $24K.
  • Cable Hill Partners first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Cable Hill Partners's Juno Therapeutics, Inc. position peaked at $24K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Cable Hill Partners's 13F filing for Q1 2018, filed 20 Apr 2018.